Jun 23, 2026, 08:59 PM IST IST Navin Fluorine Intl. - Board Meeting Intimation for Inter-Alia, To Consider, Approve And Take On Record, The Unaudited Stand Jun 06, 2026, 12:48 AM IST IST Navin ...

Navin Fluorine International Limited is an India-based company that is primarily focused on fluorine chemistry, which produces refrigeration gases, inorganic fluorides, specialty organofluorines. The ...

If you receive JavaScript required to sign in error message when using Skype, OneDrive, Teams or any other program, you need to turn on or enable JavaScript in your ...

Navin Fluorine International Limited was incorporated on June 25, 1998. AS a flagship, Company belongs to a reputed industrial house of Padmanabh Mafatlal Group in India. It has largest integrated ...

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, ...

MOUNT PLEASANT, S.C. (WCIV) — (UPDATE, 11:04 p.m.) — Republican gubernatorial candidate Rom Reddy conceded his bid for South Carolina governor Tuesday night, ending a campaign that began just three ...

Sumathi Reddy is the "Your Health" columnist at The Wall Street Journal, writing about all things health and medicine. Her columns cover everything from exercise and weight-loss drugs to cannabis and ...

WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CHARLESTON — Two leading Republican candidates for governor publicly defended nomination rival Rom Reddy on June 8 after a series of anonymous attacks targeted him and his Indian heritage. Lt. Gov.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...

Revenue from operations rose year-on-year by 16.45% at ₹701 crore from ₹602 crore in Q4 FY24.